2022 - Research.com Biology and Biochemistry in Germany Leader Award
2018 - The Brain Prize, Lundbeck Foundation For their groundbreaking research on the genetic and molecular basis of Alzheimer’s disease, with far-reaching implications for the development of new therapeutic interventions as well as for the understanding of other neurodegenerative diseases of the brain'
2015 - Metlife Foundation Award for Medical Research in Alzheimer's Disease
2003 - German National Academy of Sciences Leopoldina - Deutsche Akademie der Naturforscher Leopoldina – Nationale Akademie der Wissenschaften Agricultural and Nutritional Sciences
2002 - Potamkin Prize for Research in Pick's, Alzheimer's, and Related Diseases, American Academy of Neurology
2002 - Sedgwick Memorial Medal, American Public Health Association
2000 - Member of Academia Europaea
Member of the European Molecular Biology Organization (EMBO)
His primary areas of study are Cell biology, Biochemistry, Presenilin, Molecular biology and Amyloid precursor protein secretase. Christian Haass has researched Cell biology in several fields, including Parkin, Protease and Neurodegeneration. His studies in Biochemistry integrate themes in fields like Alpha secretase and Senile plaques.
His Presenilin research includes themes of Membrane protein and Notch signaling pathway. His biological study spans a wide range of topics, including Genetics, Mutant, Gene and Transfection. His Amyloid precursor protein secretase study integrates concerns from other disciplines, such as Neuroscience and Ectodomain.
Christian Haass spends much of his time researching Cell biology, Biochemistry, Presenilin, Pathology and Neurodegeneration. Christian Haass interconnects Transmembrane domain, Neuroscience and Amyloid precursor protein in the investigation of issues within Cell biology. His work investigates the relationship between Biochemistry and topics such as Amyloid precursor protein secretase that intersect with problems in Gamma secretase.
His Presenilin study combines topics in areas such as Molecular biology, Mutant and Amyloid. His Pathology research is multidisciplinary, relying on both Genetically modified mouse and In vivo. The Neurodegeneration study combines topics in areas such as Frontotemporal lobar degeneration, Amyotrophic lateral sclerosis, TREM2, Microglia and Cognitive decline.
The scientist’s investigation covers issues in Microglia, TREM2, Pathology, Disease and Internal medicine. His Microglia research incorporates themes from Amyloid, Phenotype, Neuroinflammation, Neuroscience and Amyloidosis. His Amyloid research is multidisciplinary, incorporating perspectives in Alzheimer's disease and Transgene.
His research integrates issues of Receptor, Innate immune system, Neurodegeneration and Cell biology in his study of TREM2. The concepts of his Cell biology study are interwoven with issues in Frontotemporal lobar degeneration, Neurotransmission, Peptide and Amyloid precursor protein. Christian Haass combines subjects such as Pi and In vivo with his study of Pathology.
Christian Haass mainly investigates Microglia, TREM2, Cell biology, Neuroscience and Receptor. In his study, which falls under the umbrella issue of Microglia, Functional studies, Aβ deposition, Potential biomarkers, Phagocytosis and Proteome is strongly linked to Phenotype. His TREM2 research includes elements of Loss function, Neurodegeneration, Gene silencing, Monoclonal antibody and Amyloid.
His work carried out in the field of Amyloid brings together such families of science as Endocrinology, Cerebrospinal fluid and Neuroinflammation. His research in Cell biology is mostly focused on Protein folding. His Genetically modified mouse research extends to the thematically linked field of Neuroscience.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Soluble protein oligomers in neurodegeneration: lessons from the Alzheimer's amyloid beta-peptide.
Christian Haass;Dennis J. Selkoe.
Nature Reviews Molecular Cell Biology (2007)
Amyloid β-peptide is produced by cultured cells during normal metabolism
Christian Haass;Michael G. Schlossmacher;Michael G. Schlossmacher;Albert Y. Hung;Carmen Vigo-Pelfrey.
Nature (1992)
Mutation of the β-amyloid precursor protein in familial Alzheimer's disease increases β-protein production
Martin Citron;Tilman Oltersdorf;Christian Haass;Lisa McConlogue.
Nature (1992)
Constitutive and regulated α-secretase cleavage of Alzheimer’s amyloid precursor protein by a disintegrin metalloprotease
Sven Lammich;Elzbieta Kojro;Rolf Postina;Sandra Gilbert.
Proceedings of the National Academy of Sciences of the United States of America (1999)
Amyloidogenic processing of the Alzheimer β-amyloid precursor protein depends on lipid rafts
Robert Ehehalt;Patrick Keller;Christian Haass;Christoph Thiele.
Journal of Cell Biology (2003)
Targeting of cell-surface β-amyloid precursor protein to lysosomes: alternative processing into amyloid-bearing fragments
Christian Haass;Edward H. Koo;Angela Mellon;Albert Y. Hung.
Nature (1992)
Cellular processing of β-amyloid precursor protein and the genesis of amyloid β-peptide
Christian Haass;Dennis J. Selkoe.
Cell (1993)
Reconstitution of γ-secretase activity
Dieter Edbauer;Edith Winkler;Joerg T. Regula;Brigitte Pesold.
Nature Cell Biology (2003)
The C9orf72 GGGGCC Repeat Is Translated into Aggregating Dipeptide-Repeat Proteins in FTLD/ALS
Kohji Mori;Shih-Ming Weng;Thomas Arzberger;Stephanie May.
Science (2013)
Aβ42‐driven cerebral amyloidosis in transgenic mice reveals early and robust pathology
Rebecca Radde;Tristan Bolmont;Stephan A Kaeser;Janaky Coomaraswamy.
EMBO Reports (2006)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:
Ludwig-Maximilians-Universität München
Ludwig-Maximilians-Universität München
German Center for Neurodegenerative Diseases
German Center for Neurodegenerative Diseases
Ludwig-Maximilians-Universität München
Brigham and Women's Hospital
University of Bonn
German Center for Neurodegenerative Diseases
University of Tübingen
University of California, Los Angeles
Inserm : Institut national de la santé et de la recherche médicale
Publications: 121
IBM (United States)
Eindhoven University of Technology
Lund University
German Cancer Research Center
Fukushima Medical University
University of Melbourne
Lawrence Livermore National Laboratory
Brandon University
University of Edinburgh
Helsinki University Hospital
Knox College
University of Southern Denmark
University of Colorado Denver
University of South Australia
University of North Carolina at Chapel Hill
George Institute for Global Health